
The flexible dosing schedule has been approved for patients with skin, lung and cervical cancer

This rare, chronic autoimmune disease can cause kidney failure if left untreated

The funding will be for a GLP-1 receptor agonist clinical programme for weight loss

The Krascendo 1 study showed improved survival rates of 18 months compared to 12 months with current standard of care

NSV is a chronic autoimmune disease where the immune system attacks melanin-producing cells, leading to a loss of pigment

If approved, this treatment would offer a new option for the nearly one million Americans living with MS

If approved, this would be the first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica

The two companies aim to discover and develop novel bispecific antibodies for immunology and inflammation diseases

The results from a global phase 3 trial show the longest survival data ever reported in this setting

MOGAD, a rare disease of the central nervous system, can attack optic nerves, the spinal cord and the brain

There are currently no approved human vaccines for Lyme disease

Litfulo delivered significant, clinically meaningful improvements for both face and body